The report forecasts the global gout therapeutics market to grow at a CAGR of 17.16% during the period 2016-2020.
The report has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
The use of regenerative medicine is an emerging treatment option for the treatment of gout. These regenerative medicines help in the healing process by replacement or regeneration of the human cells, tissues or organs, and thus help in establishing the normal function. The various regenerative techniques include cell therapy, growth factor therapy, and others.
According to the report, introduction of novel urate-lowering agents will drive growth in this market.Urate-lowering agents are increasingly becoming the preferred choice of treatment for gout, which will be used as add-on therapy to the existing standard of care and target the gout patients who failed the previous treatment.
Further, the report states that the use of CAM for the treatment of gout is one challenge, which is expected to be increase during the forecast period. The National Arthritis Foundation reveals that more than one-third of gout arthritis patients in the US prefer CAM therapies.